Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001882909-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Jan 31, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
39,673
Total Value
$139,175.96
P&L
+inf% (+$979,624.80)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, CHIEF ACCOUNTING OFFICER | Common Stock | โ | Jan 31, 2026 | Grant/Award | 15,180 | $0.00 | $0.00 | 53,413 | Direct | โ | View Details | |
SVP, CHIEF ACCOUNTING OFFICER | Common Stock | โ | Feb 3, 2026 | Sale | 4,333 | $32.12 | $139,175.96 | 49,080 | Direct | โ | View Details | |
SVP, CHIEF ACCOUNTING OFFICER | Employee stock option (right to buy) | Derivative | Jan 31, 2026 | Grant/Award | 20,160 | $0.00 | $0.00 | 20,160 | Direct | โ | View Details |